Abstract: The present invention relates to a compound of the formula [I]: wherein (a), in which -Y6 area R5 each as defined in the description, etc., R1 is hydrogen, halogen, lower alkyl, hydroxy, etc., R2 is hydrogen, lower alkyl or hydroxy(lower)alkyl, R3 is hydrogen or an amino protective group, 20 R7 is hydrogen, lower alkyl, cyclo(lower)alkyl, lower R9 alkenyl, -Z-R9 or (b), in which -Z- is -0-, -S-, R9 -SO- or -SO2-, and each R9 is independently hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R8 is -D-E-R10, in which -D- is -CONHSO2- or -S02NHCO-, E is bond or lower alkylene, and R10 is halogen, cyano, carboxy, etc., or a prodrug thereof or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of ulcer, overactive bladder, and the like.
| # | Name | Date |
|---|---|---|
| 1 | 1176-chenp-2007 pct 21-03-2007.pdf | 2007-03-21 |
| 1 | 1176-CHENP-2007_EXAMREPORT.pdf | 2016-07-02 |
| 2 | 1176-chenp-2007 form-2 21-03-2007.pdf | 2007-03-21 |
| 2 | 1562-2007-AnnexureTo Form 3.pdf | 2014-04-11 |
| 3 | 1562-2007-Petition 137 Annex Form 3.pdf | 2014-04-11 |
| 3 | 1176-chenp-2007 description(complete) -1 21-03-2007.pdf | 2007-03-21 |
| 4 | 1176-chenp-2007 description(complete) 21-03-2007.pdf | 2007-03-21 |
| 4 | 1176-CHENP-2007 AMENDED CLAIMS 09-04-2014.pdf | 2014-04-09 |
| 5 | 1176-chenp-2007 claims 21-03-2007.pdf | 2007-03-21 |
| 5 | 1176-CHENP-2007 AMENDED PAGES OF SPECIFICATION 09-04-2014.pdf | 2014-04-09 |
| 6 | 1176-chenp-2007 abstract 21-03-2007.pdf | 2007-03-21 |
| 6 | 1176-CHENP-2007 EXAMINATION REPORT REPLY RECEIVED 09-04-2014.pdf | 2014-04-09 |
| 7 | 1176-CHENP-2007 POWER OF ATTORNEY 09-04-2014.pdf | 2014-04-09 |
| 7 | 1176-chenp-2007 form-5 21-03-2007.pdf | 2007-03-21 |
| 8 | 1176-CHENP-2007 PRIORITY DOCUMENT 09-04-2014.pdf | 2014-04-09 |
| 8 | 1176-chenp-2007 form-3 21-03-2007.pdf | 2007-03-21 |
| 9 | 1176-CHENP-2007 CORRESPONDENCE OTHERS 15-10-2013.pdf | 2013-10-15 |
| 9 | 1176-chenp-2007 form-1 21-03-2007.pdf | 2007-03-21 |
| 10 | 1176-chenp-2007 correspondence others 21-03-2007.pdf | 2007-03-21 |
| 10 | 1176-CHENP-2007 FORM-3 15-10-2013.pdf | 2013-10-15 |
| 11 | 1176-CHENP-2007 CORRESPONDENCE OTHERS 12-06-2013.pdf | 2013-06-12 |
| 11 | 1176-chenp-2007 form-3 20-09-2007.pdf | 2007-09-20 |
| 12 | 1176-chenp-2007 correspondence others 20-09-2007.pdf | 2007-09-20 |
| 12 | 1176-CHENP-2007 FORM-18.pdf | 2012-03-14 |
| 13 | 1176-chenp-2007 correspondence others 20-09-2007.pdf | 2007-09-20 |
| 13 | 1176-CHENP-2007 FORM-18.pdf | 2012-03-14 |
| 14 | 1176-CHENP-2007 CORRESPONDENCE OTHERS 12-06-2013.pdf | 2013-06-12 |
| 14 | 1176-chenp-2007 form-3 20-09-2007.pdf | 2007-09-20 |
| 15 | 1176-chenp-2007 correspondence others 21-03-2007.pdf | 2007-03-21 |
| 15 | 1176-CHENP-2007 FORM-3 15-10-2013.pdf | 2013-10-15 |
| 16 | 1176-CHENP-2007 CORRESPONDENCE OTHERS 15-10-2013.pdf | 2013-10-15 |
| 16 | 1176-chenp-2007 form-1 21-03-2007.pdf | 2007-03-21 |
| 17 | 1176-CHENP-2007 PRIORITY DOCUMENT 09-04-2014.pdf | 2014-04-09 |
| 17 | 1176-chenp-2007 form-3 21-03-2007.pdf | 2007-03-21 |
| 18 | 1176-CHENP-2007 POWER OF ATTORNEY 09-04-2014.pdf | 2014-04-09 |
| 18 | 1176-chenp-2007 form-5 21-03-2007.pdf | 2007-03-21 |
| 19 | 1176-chenp-2007 abstract 21-03-2007.pdf | 2007-03-21 |
| 19 | 1176-CHENP-2007 EXAMINATION REPORT REPLY RECEIVED 09-04-2014.pdf | 2014-04-09 |
| 20 | 1176-chenp-2007 claims 21-03-2007.pdf | 2007-03-21 |
| 20 | 1176-CHENP-2007 AMENDED PAGES OF SPECIFICATION 09-04-2014.pdf | 2014-04-09 |
| 21 | 1176-chenp-2007 description(complete) 21-03-2007.pdf | 2007-03-21 |
| 21 | 1176-CHENP-2007 AMENDED CLAIMS 09-04-2014.pdf | 2014-04-09 |
| 22 | 1562-2007-Petition 137 Annex Form 3.pdf | 2014-04-11 |
| 22 | 1176-chenp-2007 description(complete) -1 21-03-2007.pdf | 2007-03-21 |
| 23 | 1562-2007-AnnexureTo Form 3.pdf | 2014-04-11 |
| 23 | 1176-chenp-2007 form-2 21-03-2007.pdf | 2007-03-21 |
| 24 | 1176-CHENP-2007_EXAMREPORT.pdf | 2016-07-02 |
| 24 | 1176-chenp-2007 pct 21-03-2007.pdf | 2007-03-21 |